China News
-
What were the top 20 M&A deals in pharma and biotech sector in 2012?
China | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...Read more
-
WuXi opens first cGMP biologics facility in China
China | News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2012
Singapore: WuXi AppTec has invested substantially in building its capabilities and capacity in biologics in the past fe...Read more
-
Accuray showcases CyberKnife, TomoTherapy Systems at CHINA-HOSPEQ 2013
China | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2013
Singapore: US-based Accuray showcased its CyberKnife and TomoTherapy Systems at 22nd China International Medical Instrum...Read more
-
Zhejiang, Celsion terminate cancer drug deal
China | News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2013
Singapore: Zheijang Hisun Pharmaceutical is looking to discontinue the exclusive option to license ThermoDox in China. T...Read more
-
Charles River buys Vital River in China
China | News | By BioSpectrum Bureau | 0 Comment | 01 Nov, 2012
Singapore: Charles River Laboratories International has entered into an agreement to acquire 75 percent ownership of Vi...Read more
-
German vaccine delivery company enters China
China | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2013
Singapore: German company Injex Pharma registered Injex30 needle free injection system with the Chinese State Food and D...Read more
-
Chinese police probe GSK staff for 'economic crimes'
China | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: The Chinese police have been investigating senior staff from the Chinese office of the British drug major Gl...Read more
-
China | Company results | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
‎Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourci...Read more
-
Sinopharm bullish on expansion
China | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2012
Sinopharm Group continued to dominate the pharmaceutical industry in China and across the Asia Pacific region ...Read more
-
Medtech companies need to bring innovation: PwC
China | Analysis | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Medical technology companies may be losing their competitive edge and are in need of a different approach to ...Read more
-
Pfizer cancer drug gets first-ever China SFDA nod
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Feb, 2013
Singapore: Pfizer received approval for Xalkori (crizotinib) for Chinese State Food and Drug Administration (SFDA), as t...Read more
-
Asia vaccine strategists call for collaboration
China | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...Read more
-
BIO 2014: Global innovation shifting to China
China | Analysis | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
San Diego: Multinational biotech companies and bioclusters of Boston, California and Germany are increasingly making t...Read more
-
Eli Lilly, China firm to co-develop diabetes drug
China | News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop L...Read more
-
ScinoPharm, Coland develop cancer generics in China
China | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2013
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...Read more
-
Using rice grains as factories for producing medicines
China | Opinion | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2012
Human serum albumin (HSA) is a soluble protein that functions primarily as a carrier protein for steroids, fatty acids...Read more
-
World Bank: China needs healthcare reforms
China | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2014
Singapore: Gripped by an endemic of lifestyle diseases, China has now been called upon by the World Bank to bring about ...Read more
-
Quintiles China report: Low household income is challenge for pharma
China | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012
Singapore: A new Economist Intelligence Unit (EIU) report sponsored by Quintiles concludes that "China is a complex mark...Read more
